Results 91 to 100 of about 3,779 (110)

CD55 in cancer: Complementing functions in a non-canonical manner

Cancer Letters, 2022
Ofer Reizes
exaly  

The genetic and epigenetic regulation of CD55 and its pathway analysis in colon cancer

Frontiers in Immunology, 2023
Zhenbang Yang, Ji Shanshan, Wu Hongjiao   +2 more
exaly  

The active form of Helicobacter pylori vacuolating cytotoxin induces decay‐accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa

Journal of Pathology, 2022
Kazuyo Kaneko, Karen Robinson, Ian Spendlove   +2 more
exaly  

CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors

Journal of Experimental Medicine, 2017
Chad Michener, Keith Mccrae, Analisa Difeo   +2 more
exaly  

The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).

Journal of Experimental Medicine, 1996
Van Lier R A
exaly  

CD55 is over-expressed in the tumour environment

British Journal of Cancer, 2001
L G Durrant, Durrant L G
exaly  

Inhibition of Decay-Accelerating Factor (CD55) Attenuates Prostate Cancer Growth and Survival In Vivo

Neoplasia, 2006
Kenneth Pienta, Rodney Dunn, Robert D Loberg   +2 more
exaly  

Decay-accelerating factor (CD55) deficiency phenotypes in Japanese

Transfusion Medicine, 1998
C A Green, G Mallinson, G L Daniels
exaly  

The role of CD55 in protecting the tumour environment from complement attack

Tissue Antigens, 2002
L G Durrant
exaly